Transient FY26 For Syngene But Momentum In China +1 Projects

Supply Chain
Syngene reaps gains of China +1 rebalancing (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Business